P D Davis
Overview
Explore the profile of P D Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis P, Dennis J, Railton R
J Hum Hypertens
. 2004 Nov;
19(3):197-203.
PMID: 15565174
The performance of five units of the A&D UA-767 NIBP monitor and five units of the Welch Allyn Spot Vital Signs noninvasive blood pressure monitor was evaluated with the Biotek...
2.
Moffat D, Allen R, Rapecki S, Davis P, OConnell J, Hutchings M, et al.
Curr Med Chem
. 2004 Mar;
11(6):747-53.
PMID: 15032728
We have developed a series of 4-thiophenoxy-N-(3,4,5-trialkoxyphenyl) pyrimidine-2-amines as potent and selective inhibitors of p56lck tyrosine kinase activity. In particular, the most potent inhibitor shows cellular activity in T-cell receptor...
3.
Davis P, Raffen R, Dul L, Vogen M, Williamson K, Stevens J, et al.
Immunity
. 2000 Nov;
13(4):433-42.
PMID: 11070162
Immunoglobulin light chain (LC) normally is a soluble, secreted protein, but some LC assemble into ordered fibrils whose deposition in tissues results in amyloidosis and organ failure. Here we reconstitute...
4.
Press J, Davis P, Wiesner S, Heinemann A, Semik P, Addison R
Clin J Sport Med
. 1995 Oct;
5(4):236-40.
PMID: 7496848
While there have been numerous reports in the literature of accidents in equestrian sports, no comprehensive study has been conducted to ascertain the nature and incidence of injuries incurred by...
5.
Davis P
Nurs Manage
. 1995 Jul;
26(7):32A, 32D-32F, 32H.
PMID: 7603670
Health-care managers have a responsibility to create harmony within the workforce, increasingly a culturally diverse group. Suggestions offered by the literature for actions a manager can take to deal effectively...
6.
Pellegrini A, Davis P
Br J Educ Psychol
. 1993 Feb;
63 ( Pt 1):88-95.
PMID: 8466835
In this within-subjects design field experiment children's behaviour in the playground was charted as a function of gender and time in the classroom immediately preceding playtime. Playground behaviour was also...
7.
Bit R, Davis P, ELLIOTT L, Harris W, Hill C, Keech E, et al.
J Med Chem
. 1993 Jan;
36(1):21-9.
PMID: 8421286
The protein kinase inhibitor staurosporine has been used to design a series of selective bisindolylmaleimide inhibitors of protein kinase C (PKC). Guided by molecular graphics, conformational restriction of the cationic...
8.
Mulqueen M, Bradshaw D, Davis P, Elliott L, Griffiths T, Hill C, et al.
Agents Actions
. 1992 Sep;
37(1-2):85-9.
PMID: 1456183
The protein kinase C family of enzymes is thought to be important in mediating signal transduction. Ro 31-8830 is a novel, potent inhibitor of protein kinase C, derived from the...
9.
Nixon J, Bishop J, Bradshaw D, Davis P, Hill C, ELLIOTT L, et al.
Biochem Soc Trans
. 1992 May;
20(2):419-25.
PMID: 1397642
No abstract available.
10.
Davis P, ELLIOTT L, Harris W, Hill C, Hurst S, Keech E, et al.
J Med Chem
. 1992 Mar;
35(6):994-1001.
PMID: 1552513
A hypothetical mode of inhibition of protein kinase C (PKC) by the natural product staurosporine has been used as a basis for the design of substituted bisindolylmaleimides with improved potency...